Persistence Market Research
ORF is a protein translated from RNA messenger, which is transcribe through DNA. Dueing the translation process three nucleotide codons are required among mainly for protein synthesis. The one that starts and stops this translation is known as ORF. Opening reading frame (ORF) clones helps in eliminating wearisome steps of RNA isolation, PCR amplification, DNA synthesis, and other tedious sequencing and validation process.
Currently application of ORF expression clones is increasing in functional assays, recombinant protein expression, protein characterization, In-virto transcription, and few others. In virto transcription has shown largest demand for the ORF expression clones. Growing research and development mainly for early diagnosis and detection of diseases has boosted demand in the global ORF expression clones market.
Moreover, growing number of hospitals and diagnostic laboratories and increased expenditure on healthcare sector further fueled demand in this market. Increasing prevalence of cell based diseases like cancer and autoimmune diseases also requires the detection and diagnosis of specific tissue and cell, growing demand for personalized medicines that needs the study of individual cell structure and function, and rise in number of biopsy procedures have further augmented demand in the global ORF expression clones market.
Growing research and development activities by biotechnology and pharmaceutical companies and rapid process/product development due to fewer steps has augmented demand in the global ORF expression clones market. Moreover, increased awareness about new product launch is benefitting growth in this market
ORF Expression Clones Market: Snapshot
Open reading frame (ORF) clones have gained steam as a high-throughput cloning, especially for protein expression when the functional information is limited. The staggering numbers of proteins revealed by genomics have bolstered the demand for this fast and flexible cloning system. ORF expression clones when used in conjunction with high-end proteomics platforms paves way to new frontiers in functional proteomics. Notable platforms include protein microarrays and cell-based assays. This is fueled in part by the demand for better treatments of cell-based diseases notably cancer. Growing popularity of functional genomics and functional proteomics is fueling the need for ORF clones. Emerging genes encoding proteins with limited understanding has been propelling the use of ORF expression clones. Adoption of functional proteomics approaches in oncology research has expanded the potential of the ORF expression clones market. Their adoption in breast cancer is an important case in point.
Advances made in cell based methods, in vivo as well as in vitro systems, are bolstering the prospects of the ORF expression clones market. ORF expression clones have helped in the scaling of high-throughput cloning for studying biological activity in several newly discovered proteins. In this regard, the use of robust and stable enzymes is boosting the market. Growing gene discovery research in developed countries is catalyzing the demand for ORF expression clones. The availability of a variety of expression-ready ORF clones bodes well for the market. Key players are aiming at offering a wide collection of ORF expression clones to meet a variety of the needs of researchers.
DNA is transcribe into messenger RNA, messenger RNA is translated into protein ORF. During translation, the combination of three nucleotide codons are required for protein synthesis. The nucleotide that starts translation and stops translation is known as ORF. Every DNA has six open reading frame and it is important to determine the correct open reading frame so that the protein is expressed properly. An Open Reading Frame starts with ATG (Met), which is known as start codon and ends with DNA sequence such as TAA, TAG, TGA known as stop codon. ORF clones are eliminates the wearisome steps of RNA isolation, DNA synthesis, PCR amplification and other tedious sequencing and validation procedures.
The ORF expression clones are plasmid that contains protein coding DNA, the DNA contains the coding sequence without 5' and 3' end untranslated regions. The ORF expression clones helps to save as it moves directly protein expression and protein analysis. The ORF clones aids to get protein expression and analysis faster. The ORF allows to get gene of interest and expressed protein quickly, and help researchers to conduct clinical and medical applications. Clinical laboratory are highly equipped with assay and instrument systems used for the detection and classification of various disease type such as cancer and risk of cancer progressions, cardiovascular diseases, and others. The advancement in the molecular genetics, bioinformatics, proteomics, increasing number of infection rate is prompting manufacturers to seek newer methods of research, has led to the revenue growth over the forecast period.
Increased demand for research and development for early detection and diagnosis of disease, increased expenditure on healthcare sector, growing number of hospitals and diagnostic laboratories, increased demand for personalized medicines requires the study of individual cell structure and function, rise in prevalence of cell based diseases such as cancer and autoimmune diseases requires the detection and diagnosis of specific cell and tissue, rise in number of biopsy procedures. Technological advancement in the diagnostic and treatment process of infectious diseases, advancement in molecular techniques are the factors fueling the demand of ORF expression clone market in the near future.
The global ORF expression clones market is segmented on basis of expression system,application, end user and geography
Segment by Expression System
Segment by Application
Segment by End User
Global ORF expression clones is segmented by expression system, application and end user. On the basis of expression system the, ORF expression clones market is segmented as mammalian expression system, lentiviral expression system, bacterial expression system, yeast expression system, insect, wheat germ cell and others. Based on the application type, global ORF expression clones market is segmented as recombinant protein expression, functional assays, protein characterization, In vitro transcription and other application for research and study purpose. On the basis of end user, the global ORF expression clones market is segmented into biotechnological companies, pharmaceutical companies, contract research organizations, academic/ research institutes. Increasing outsourcing by pharmaceutical and biotechnological companies, declining R&D productivity and patent cliff sales drop leading to increasing research intensity in the pharmaceuticals sector, rapid process/product development due to fewer steps, increased awareness about new product launch and others are some of the factors drive the global ORF expression clones market during the forecast period. Whereas high cost and short reaction scale, low protein expression, inadequate access to health care, lack of standardized tools for research and development are some of the factors that may hamper the growth of global ORF expression clones market.
By Geography, the global ORF Expression Clones market is segmented into five broad regions viz. North America, Latin America, Europe, Asia-Pacific, and the Middle East & Africa. North America is estimated to lead the global ORF expression clones market due to increasing focus on protein expression and production, growing demand for simple and efficient protein production methods, government funding for research and development in developed countries and others. Europe market is also projected to experience high growth due to emphasis on up-scaling and industrial application in the near future. Asia Pacific market is anticipated to grow at the fastest growth rate during the forecast period, owing to factors such as focusing on healthcare expenditures, rise in research and development facilities and others.
Some of the major players in global ORF expression clones market are Thermo Fisher Scientific, GeneCopoeia, Inc. Dharmacon, Inc., BioCat GmbH, Source BioScience, Kabushiki Kaisha DNAFOR, GenScript, OriGene Technologies, Inc. Sino Biological Inc. Promega Corporation and Others.
MRR.BIZ has been compiled in-depth market research data in the report after exhaustive primary and secondary research. Our team of able, experienced in-house analysts has collated the information through personal interviews and study of industry databases, journals, and reputable paid sources.
The report provides the following information:
The main aim of the report is to:
MRR.BIZ is a leading provider of strategic market research. Our vast repository consists research reports, data books, company profiles, and regional market data sheets. We regularly update the data and analysis of a wide-ranging products and services around the world. As readers, you will have access to the latest information on almost 300 industries and their sub-segments. Both large Fortune 500 companies and SMEs have found those useful. This is because we customize our offerings keeping in mind the specific requirements of our clients.